CytoDyn Inc. (CYDY) - OTCQB
  • pakjb1 | Send Message 14 Jul

    $CYDY Is anyone covering this small company? HIV trials for two years with great success.
      • wilkinson99 | Send Message 5 Apr

        Top % Gainer $5 or less: $SUNEQ 67%, $INVT 35%, $SEED 34%, $SHRK 26%, $ORIG 16%, $PVHO 15%, $LINEQ $KUTV $LNCOQ $GLUU $TWER $TVIX $SID $CYDY
        Reply (1)
        • Shane_Murray | Send Message 5 Apr
          : $SUNEQ is almost 97%. But it still doesn't change the situation for the better.
          • wilkinson99 | Send Message 30 Mar

            $DRWI 45%, $XTNT 22%, $YOD 16%, $EGY 13%, $OXGN $ACAD $IOC $CRC $VNR $SUNEQ $GGB $CYDY $YRD $LGCY $RH $TPLM $LDRH $MNOV $LEU
              • Robert A. Desmond | Send Message 3 Feb

                {video} Best Stock Charts $ERY $YHOO $CYDY $CIT $TVIX $SPXS $NTAP $LION $UWTI $UTG $UUP $GLD
                  • Robert A. Desmond | Send Message 9 Dec 2015

                    {video} Stock Chart Analysis $JO $BTG $RIC $RAS $CYDY $FTK $EXXIQ $FCX $AUY $HPQ $XOMA $SUNEQ
                    Reply (1)
                    • Robert A. Desmond | Send Message 20 Jan
                      : Old news! Watch the $UUP because once it breaks $GLD $GDX $NUGT , $USO, $UWTI $SLV you get my drift all rally. ECB meets tomorrow $FXE spike
                      • Kanak Kanti De | Send Message 30 Nov 2015

                        Cytodyne's PRO 140: Better Safety, Non-Inferior Efficacy In HIV $CYDY
                          • JFSigerson | Send Message 7 Nov 2014

                            Taking Action Now: In Search Of Viable HIV-1 Treatments For Developing Nations $CYDY
                              • adbeeston | Send Message 7 Nov 2014

                                Ready To Invest In Biotech? Now Seems Like The Perfect Time $CYDY
                                  • domeinhorn | Send Message 6 Nov 2014

                                    4 Things You Need To Know About HIV In 2014—including A Breakthrough “non-Drug” Treatment $CYDY
                                      • domeinhorn | Send Message 6 Nov 2014

                                        Biotech Firm: Switching To Monotherapy, Antibody Treatment Versus HAART Will Greatly Benefit HIV... $CYDY
                                          Company Description
                                          CytoDyn is a publicly traded biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses. CytoDyn's lead product candidate, PRO 140, has the potential to drive groundbreaking advancements in developing the next generation of HIV... More
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States